Why Pharma Supply Chains Are Breaking And How Concurrent Planning Fixes It
The pharmaceutical supply chain operates under pressures that most industries never face: regulatory scrutiny at every node, life-or-death consequences for stockouts, and a complexity that spans continents, cold chains, and compliance frameworks. Yet many pharma organizations are still navigating this complexity with disconnected spreadsheets, siloed data, and planning cycles that take days — not minutes — to respond to disruption.
The result? Forecast errors cascade unchecked. Inventory either piles up in the wrong location or runs dangerously thin. And S&OP meetings become exercises in reconciling conflicting numbers rather than making confident decisions.
There is a better way — and it starts with rethinking how planning itself works.
The Hidden Cost of Sequential Planning
Most supply chain planning tools work sequentially: demand planning runs first, then supply planning adjusts, then finance reviews. Each step is a handoff. Each handoff introduces lag, translation errors, and assumptions that may no longer hold by the time the next team opens the spreadsheet.
In pharmaceuticals, this model is especially costly. A demand signal shift — a regulatory filing, a competitor recall, an unexpected clinical trial outcome — doesn’t wait for your planning cycle to catch up. By the time the signal reaches the supply team, the window to respond has already narrowed.
Sequential planning treats complexity as something to be managed in turns. Pharma supply chains don’t move in turns.
Concurrent Planning: A Different Model
Kinaxis® Planning One™, available through Simbus, is built on a fundamentally different premise: all planning happens at the same time, on the same data, across every function.
Demand planners, supply planners, and finance teams are no longer working in isolated silos handing off to one another. They work concurrently — seeing the same numbers, running scenarios against the same model, and watching how a change in one area ripples through the entire network in real time.
This isn’t a cosmetic improvement to existing workflows. It’s a structural change in how planning decisions get made.
What Changes for Pharma Organizations
Forecast Errors Shrink — And Propagate Less
In a concurrent model, demand signals are immediately visible to supply planners. When a forecast shifts, the downstream impact is calculated automatically and surfaced to every relevant stakeholder at once. There’s no lag between “we know demand is up 18% for this SKU” and “supply knows and is already modeling the response.”
The result: fewer surprises at month-end, fewer emergency air freight decisions, and far less inventory written off due to expiry.
Inventory Visibility Becomes Actual Visibility
“Inventory visibility” is a phrase that appears in nearly every supply chain pitch deck — but in most pharma organizations, it means running a report that’s already hours or days old. Kinaxis Planning One™ connects to live data across your network, giving planners a real-time picture of where inventory sits, what’s at risk of expiring, and where safety stock is dangerously low.
For regulated products with strict shelf-life requirements, this isn’t a nice-to-have. It’s the difference between proactive allocation and reactive damage control.
S&OP Becomes a Decision-Making Forum, Not a Reconciliation Exercise
One of the most consistent frustrations we hear from pharma supply chain leaders is this: S&OP meetings are consumed by debating which version of the data is correct. By the time the team agrees on a baseline, there’s no time left to actually make decisions.
Concurrent planning solves this at the source. When everyone works from the same live model, the S&OP meeting starts with alignment, not argument. Scenario analysis — what happens if we shift production from Site A to Site B? what’s our exposure if this supplier delays by two weeks? — can be run during the meeting, not prepared beforehand and presented as static slides.
A Platform Built for the Complexity Pharma Requires
Kinaxis Planning One™ is purpose-built for organizations where supply chain complexity is a given, not an exception. For pharma, that means:
- Multi-tier network modeling across contract manufacturers, 3PLs, and distribution centers
- What-if scenario analysis that runs in seconds, not overnight
- Regulatory and compliance-aware planning that accounts for site approvals, country-of-origin requirements, and serialization constraints
- Native integration with SAP, Oracle, and other enterprise systems — so your existing data investments aren’t discarded, they’re amplified
Simbus: Your Implementation Partner
Technology is only part of the answer. The other part is implementation expertise — someone who understands both the platform and the specific operational realities of pharmaceutical supply chains.
Simbus brings both. Our team combines deep Kinaxis implementation experience with firsthand understanding of pharma’s regulatory environment, batch manufacturing constraints, and global distribution challenges. We don’t just configure software; we help you redesign planning processes so that the full value of concurrent planning is captured from day one.
The Right Time to Modernize Is Before the Next Disruption
Supply chain disruptions in pharma are not hypothetical. Regulatory holds, supplier failures, demand spikes tied to clinical events — they happen. Organizations that have modernized their planning infrastructure respond faster, waste less, and protect patient access to therapies. Organizations still running on spreadsheets spend that same crisis scrambling to understand what they have and where it is.
If your planning infrastructure is built for a world that no longer exists, now is the time to change that.
Talk to Simbus about Kinaxis® Planning One™ →
Simbus is a specialized supply chain transformation partner with deep expertise in Kinaxis implementations for life sciences and pharmaceutical organizations. We help planning teams move from reactive firefighting to confident, data-driven decision-making.
